Why should we avoid the use of rosiglitazone?
Mikhail
Nasser
N
D003920:Diabetes Mellitus / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000209:etiology*; D016017:Odds Ratio; D016016:Proportional Hazards Models; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone